Lakewood-Amedex Biotherapeutics
LABTOther · NASDAQ · IPO April 23, 2026
01
Company Overview
Lakewood-Amedex Biotherapeutics is filing to list on NASDAQ Capital. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Lakewood-Amedex Biotherapeutics is going public on NASDAQ Capital on 2026-04-23. Offering 4,689,177 shares.
Recent headlines
Couldn't pull live headlines right now.
02
AI Analysis
Possible growth narrative
Sits adjacent to Other — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- April 23, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Other
- Valuation
- —
- Headquarters
- —
- Attention score
- 46 / 100
- Ticker
- LABT